CRT Implantation in Patient Possesses Prominent Thebesian Valve
Abstract
CRT has been established as standard treatment for refractory heart failure in many major clinical trials. Insertion of left ventricle lead is frequently most challenging step. Coronary sinus anatomy is of the most technical burden. A case of CRT implantation with presence of prominent Thebesian valve and stenotic posterolateral vein is presented in thic case report.Downloads
Download data is not yet available.
References
Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The currentcost of heart failure to the National Health Service in the UK. Eur J Heart Fail2002;4:36171.
van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, SwedbergK. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11:1143–51.
Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, Mcmurray J, et al. 2010 Focused Update of ESC guidelines on device therapy in heart failure. Eur Heart J 2010:111.
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–53.
Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. Longterm clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026–33.
Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454–9.
Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 2003;289:2685–94.
Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverterdefibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864–8.
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–50.
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539–49.
Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. Europace 2007;9:95998.
Gorcsan J, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, et al. Echocardiography for Cardiac Resynchronization Therapy: Recommendations for Performance and Reporting–A Report from the American Society of Echocardiography Dyssynchrony Writing Group. JASE 2008;21(3):191213.
Mak GS, Hill AJ, Moisiuc F, Krishnan SC. Variations in Thebesian valve anatomy andcoronary sinus ostium: implications for invasiveelectrophysiology procedures. Europace 2009;11:118892.
van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, SwedbergK. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11:1143–51.
Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, Mcmurray J, et al. 2010 Focused Update of ESC guidelines on device therapy in heart failure. Eur Heart J 2010:111.
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–53.
Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. Longterm clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026–33.
Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454–9.
Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 2003;289:2685–94.
Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverterdefibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864–8.
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–50.
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539–49.
Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. Europace 2007;9:95998.
Gorcsan J, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, et al. Echocardiography for Cardiac Resynchronization Therapy: Recommendations for Performance and Reporting–A Report from the American Society of Echocardiography Dyssynchrony Writing Group. JASE 2008;21(3):191213.
Mak GS, Hill AJ, Moisiuc F, Krishnan SC. Variations in Thebesian valve anatomy andcoronary sinus ostium: implications for invasiveelectrophysiology procedures. Europace 2009;11:118892.
Views & Downloads
Abstract views: 2704
PDF (Bahasa Indonesia) downloads: 1947
PDF (Bahasa Indonesia) downloads: 1947
How to Cite
Mulia, E., Dewi, W., Maharani, E., & Yuniadi, Y. (1). CRT Implantation in Patient Possesses Prominent Thebesian Valve. Indonesian Journal of Cardiology, 32(4), 236-41. https://doi.org/10.30701/ijc.v32i4.84
Section
Case Reports
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
